drugset / Trial / NCT00952653
Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to evaluate the effect of desvenlafaxine administered as DVS SR on the pharmacokinetics of midazolam in healthy male and female subjects. The amount of drug in the body and the effect of the drug will also be evaluated.
Timeline
- Start
- 2010-06
- Primary completion
- 2010-08
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desvenlafaxine | Other / unclassified | 50 mg | — |
| Subject | Midazolam | Small molecule | 4 mg | — |